![Feng Ming Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Feng Ming Liu
Chief Executive Officer at Changzhou Biowin Pharmaceutical Co., Ltd.
Profile
Feng Ming Liu is currently the Chairman & General Manager at Changzhou Biowin Pharmaceutical Co., Ltd.
Previously, he worked as the Chief Executive Officer & Chief Scientist at Shineco, Inc. Liu holds a doctorate degree from Peking Union Medical College.
Feng Ming Liu active positions
Companies | Position | Start |
---|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Chief Executive Officer | 31/12/2011 |
Former positions of Feng Ming Liu
Companies | Position | End |
---|---|---|
SHINECO, INC. | Chief Executive Officer | - |
Training of Feng Ming Liu
Peking Union Medical College | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SHINECO, INC. | Process Industries |
Private companies | 1 |
---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
![]() Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Health Technology |
- Stock Market
- Insiders
- Feng Ming Liu